Workflow automation platform for the life sciences industry.
Summary
59
Insights
This section hypothesizes why Automata can be a $10 billion dollar company in 10 years, in 10 lines or less.
Automata, based in London, focuses on automating workflows within the life sciences sector. By replacing manual processes and non-specialized software tools with robust automation solutions, Automata addresses inefficiencies and high error rates that can hinder research and development. Leveraging advanced machine learning algorithms, the platform is tailored to meet the unique needs of life sciences organizations, potentially improving accuracy and operational speed. Supported by a strong group of investors, Automata is well-positioned to capitalize on the growing demand for specialized automation in health tech, addressing a crucial market gap.
Total funding Amount
Fundraising History
-
Oct 03 '23 Series B$40M
-
Feb 01 '22 Series B$50M
-
Mar 01 '19 Series A$7.4M
-
Mar 31 '16 Seed$2.1M
Investors
-
A.P. Moller HoldingSeries B
-
DimensionSeries B
-
Hummingbird VenturesSeries A
-
Octopus VenturesSeries B
-
LatitudeSeries B
-
Isomer CapitalSeries B
-
Aldea VCSeries B
-
HCVCSeries A
-
Local GlobeSeed
-
Entrepreneur FirstSeries A
-
Firstminute CapitalSeries A
-
ABB Technology VenturesSeed